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ABSTRACT
MECHANISTIC STUDIES OF PEPTIDE-MEDIATED PROTEIN TRANSPORT
ACROSS DROPLET-INTERFACE BILAYERS
MAY 2017
JING HUANG
B.S., RENMIN UNIVERSITY OF CHINA
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Matthew A. Holden
Pep-1 is a promising peptide tool that delivers proteins and peptides into
cells with conserved bioactivity. Pep-1 has great potential because of the high
efficiency and lack of toxicity. The mechanism of Pep-1-mediated transport is not
fully understood. In my thesis, droplet-interface bilayer (DIB) has been used for the
mechanistic studies of Pep-1. Here, DIB is developed for different functions such as
quantitation of protein translocation, solution exchange to a formed bilayer and
simultaneous observation of multiple membranes. Research work on Pep-1 with
DIB reveals that the negative charge of the inner membrane leaflet plays a
significant role in promoting cargo translocation. Further investigation indicates
that the transport efficiency is time-dependent and complex formation of peptide
and cargo is required.

vii

TABLE OF CONTENTS
Page
ACKNOWLEDGMENTS..............................................................................................................................v
ABSTRACT .................................................................................................................................................. vii
LIST OF FIGURES ........................................................................................................................................ x
CHAPTER
1.

INTRODUCTION ........................................................................................................................... 1
1.1 Membrane transport .......................................................................................................... 1
1.2 DIB: a potent model membrane to study membrane transport...................... 1
1.3 Pep-1: an efficient cell penetrating peptide ............................................................. 4
1.4 Overview: mechanistic studies of Pep-1 across DIBs .......................................... 5
1.5 Reference................................................................................................................................. 6

2.
DIRECT QUANTIFICATION OF PEP-1-MEDIATED HORSERADISH
PEROXIDASE TRANSPORT ACROSS DIBs ....................................................................................... 8
2.1 Introduction ........................................................................................................................... 8
2.2 Results and discussions .................................................................................................... 9
2.3 Conclusions ..........................................................................................................................15
2.4 Experimental methods ....................................................................................................16
2.4.1 Reagents ..............................................................................................................16
2.4.2 Vesicles ................................................................................................................16
2.4.3 Incubation of Pep-1 and HRP to form complexes .............................17
2.4.4 Formation of DIBs and electrophysiological recording ..................18
2.4.5 HRP assay and fluorescence microscopy ..............................................19
2.5 Supplementary information ..........................................................................................20
2.6 References.............................................................................................................................21
3.
REREPEATED ADDITION AND REMOVAL OF REAGENTS ON DROPLETINTERFACE BILAYERS ..........................................................................................................................24
viii

3.1 Introduction .........................................................................................................................24
3.2 Results and discussions ..................................................................................................25
3.3 Conclusions ..........................................................................................................................29
3.4 Experimental methods ....................................................................................................30
3.4.1 Reagents ..............................................................................................................30
3.4.2 Vesicles ................................................................................................................30
3.4.3 Incubation of Pep-1 and HRP for complexes .......................................31
3.4.4 HRP assay and fluorescence microscopy ..............................................31
3.4.5 Supplementary information .......................................................................31
3.5 Supplementary information..........................................................................................31
3.6 References ............................................................................................................................32
TIME-LAPSE FLUORESCENCE DETECTION OF PROTEIN TRANSLOCATION
ON MULTIPLE MEMBRANES ..............................................................................................................33
4.1 Introduction .........................................................................................................................33
4.2 Results and discussions ..................................................................................................35
4.3 Conclusions ..........................................................................................................................42
4.4 Experimental methods ....................................................................................................43
4.4.1 Reagents ..............................................................................................................43
4.4.2 Vesicles ................................................................................................................44
4.4.3 Incubation of Pep-1 and β-Gal to form complexes............................44
4.4.4 Formation of DIBs on dimple-chip ..........................................................45
4.4.5 Time-lapse fluorescence microscopy and β-Gal
quantitation ...........................................................................................................45
4.5 Supplementary information..........................................................................................46
4.6 References ............................................................................................................................49
5.

CONCLUSIONS AND FUTURE WORK ................................................................................52
5.1 Conclusions ..........................................................................................................................52
5.2 Future work .........................................................................................................................53
5.3 References ............................................................................................................................54

BIBLIOGRAPHY.........................................................................................................................................55

ix

LIST OF FIGURES
Figure

Page

1.1 Asymmetry on DIB by lipid-in method.................................................................................. 2
2.1 Procedure of direct quantitation of enzyme transport across DIBs ....................... 10
2.2 Methods to analyze the transport across DIBs. ............................................................... 11
2.3 Effect of potential and ratio of Pep-1 to HRP on translocation ................................. 12
2.4 Effect of charge asymmetry on translocation................................................................... 15
2.5 Snake chip for translocation to avoid possible contamination ................................. 17
2.S1 Calibration curve of the fluorescence and HRP in the droplet ............................... 20
2.S2 Electrophysiological recordings with -50mV applied across DIBs....................... 21
3.1 Fabrication of flow-chip. ............................................................................................................ 26
3.2 Demonstration of solution exchange by αHL and gCD. ................................................ 27
3.3 Peptide-assisted protein translocation on the flow device ........................................ 28
3.S1 Removal of dye from a DIB..................................................................................................... 31
3.S2 Bright-field image of flow device......................................................................................... 32
4.1 Real-time detection and quantification of peptide assisted enzyme
translocation ........................................................................................................................................... 36
4.2 Effect of charge asymmetry across bilayer on translocation..................................... 38
4.3 Effect of incubation of Pep-1 and β-Gal ............................................................................... 41
4.S1 Calculation of transported β-Gal in a droplet ................................................................ 46
4.S2 β-Gal translocation control experiments in the absence of Pep-1 ........................ 47
4.S3 Effect of of the orientation of charged asymmetric DIB on translocation ......... 48
5.1 Proposed mode of action ........................................................................................................... 53

x

CHAPTER 1
INTRODUCTION
1.1 Membrane transport
Membrane transport is significant to all cells as it regulates the delivery of
different ions and molecules through the cell membrane. Membrane permeability
maintains the concentration of solutes and ions inside the cell. The poor
permeability of the plasma membranes to potent therapeutic molecules makes them
difficult to be functional as clinic treatments.

1

Understanding the various

mechanisms involved in membrane transport is of great significance to the diseases
caused by defective ion channels, cellular uptake and drug delivery fields. The use of
live cells for investigating membrane transport mechanisms is often problematic.
The heterogeneity of cells within a population, the lack of control of membrane
components and the need to keep cells within defined physiological conditions often
complicate mechanistic nuances that govern transport. To overcome these
challenges, model membranes may be used as simplified model systems that mimic
different surface, including mammalian and bacteria cells.

2, 3

The composition,

leaflet symmetry, trans-membrane voltage, size and many other factors may be
freely manipulated with model membranes, making them ideal platforms for
mechanistic studies involving transport.
1.2 DIB: a potent model membrane to study membrane transport
The droplet-interface bilayer (DIB) is a promising tool for the mechanistic
studies of membrane transport.4,

5

To create a DIB, two lipid-coated aqueous

1

droplets are immersed in the oil phase and brought to contact.4 Oil between the
monolayers is replaced and a bilayer spontaneously forms at the interface.4, 5 DIBs
are robust bilayers which can remain intact for up to 2 weeks,4, 6 while the widely
used planar bilayers for investigating membrane transport only have a lifetime of a
few hours.5 In this thesis, the DIB is used as a model membrane to investigate
membrane transport.

Figure 1. 1 Asymmetry on DIB by lipid-in method. Droplet with lipid vesicles is
placed in oil. The vesicles fuse at the water-oil interface to form a monolayer. The
droplet is joined to another droplet containing a different lipid composition, forming
a DIB with asymmetry.
Two methods exist to create DIBs: the “lipid-out” and “lipid-in” methods. In
the lipid-out method, aqueous droplets are submerged in an oil/lipid mixture and
lipids from the oil self-assemble at the oil-water interface.4, 7 The lipid-out technique
makes monolayers identical to each other. In contrast, the lipid-in method uses lipid
vesicles to create aqueous droplets.6 When the droplets are submersed in the oil
bath, vesicles fuse at the oil-water interface to form monolayers (Figure 1.1).6 In
both approaches, monolayers are first stabilized before bilayer formation. Lipid-in
technique requires shorter time to form monolayers than lipid-out technique and is

2

less expensive due to the low consumption of lipids.6 Furthermore, when the
droplets are composed of different vesicles, an asymmetric bilayer with monolayers
of different lipid compositions is created with the lipid-in technique. Most biological
membranes have two leaflets of different lipid compositions. In eukaryotic cell
membranes, anionic lipids principally exist on the cytoplasmic surfaces whereas the
outer leaflet is mainly made of neutral lipids.8 Asymmetry is so common in nature
that it is essential to employ asymmetric bilayers in studies of membrane
phenomena like membrane transport. In the following research presented, lipid-in
technique is used to create bilayers.
DIBs enable the electrical measurements of membrane protein channels and
pores. Each droplet has an embedded electrode, which is fixed to a
micromanipulator.4,

7

The electrodes allow the application of a potential and

measurement of ionic currents.4, 7 The capacitance can be used to monitor the
formation of bilayers. DIBs can resist potential greater than 150mV.4,

6, 7

Micromanipulators control the positions of droplets so that the bilayer area is
adjusted by moving the droplets close or apart. A droplet can then be detached from
the bilayer and reform a bilayer with the same or a different partner droplet. The
capability of DIBs to separate the bilayer is beneficial to investigations of membrane
transport where the result of transport can be isolated and studied individually.
DIB has been applied to study various membrane phenomena. Membrane
proteins can be incorporated into the DIB and function the same as on the planar
bilayers, including both α-helix bundles and β-barrels.5 Asymmetric DIBs have been
used to study the effect of charge asymmetry on the gating behavior of outer
3

membrane protein G (OmpG).6 The concept of droplet-based lipid bilayer has been
spread for other functional model membrane methods. For example, droplet
networks for ion channel screening have been built on a plastic surface with a
square array of dimples;4 bilayers can form between droplet and aqueous surface
such as hydrogel.9,10
DIBs therefore have potential to be a powerful technology for membrane
transport. Various factors that are significant in the membrane transport can be
managed and studied individually using the ultra-stable DIB, such as lipid
composition, concentration of inner components and trans-membrane potential.
The DIB can easily be created with asymmetry, which is predominant in the
biological membranes. Electrophysiological measurements and fluorescence can be
used with DIBs for analysis. The ability of separating the bilayer greatly simplifies
the process to analyze the result of membrane transport.

1.3 Pep-1: an efficient cell penetrating peptide
To demonstrate that DIB is a model membrane system with applications in
transport mechanism studies, membrane translocations by cell penetrating peptides
(CPPs) were analyzed. Cell penetrating peptides (CPPs) are short amphipathic
peptides that can deliver molecules such as nucleotides, proteins and peptides to a
cell’s cytoplasm. 1 Thus, CPPs have been proposed as promising delivery vehicles to
transport molecules with therapeutic importance.

11

Several types of CPPs, such as

Tat, pAntp and transportan have been utilized to promote the delivery of protein
and peptides into cells. 1, 11, 12 Understanding the mechanism of CPPs assisting cargo
4

translocation plays an important role in predicting the function of CPPs and in
promoting new designs.

3, 13, 14

Among the various factors, a practical method to

quantify the uptake of cargo delivered by CPPs is crucial to predict the efficacy of
peptides. 14 However the quantification of single transport event is rare.
Research work on the mechanism of these CPPs suggested that they bind to
cargo molecules covalently and transport them by endosomal pathways.

11

The

covalent binding based on disulfide linkage limits the application of these CPPs as
the disulfide bond may risk the cargo activity. 15 Among the various CPPs, Pep-1 is of
particular interest as it forms complex with cargo through non-covalent
electrostatic or hydrophobic interactions, which helps preserve the cargo’s
bioactivity. 16 In addition, Pep-1 associated translocation is energy-independent and
the cargo/peptide complex dissociates rapidly upon crossing the membrane.16
Unlike other CPPs, Pep-1 is not delivered by endocytosis and a variety of
mechanisms have been proposed over the years –none have been definitive. 17, 18

1.4 Overview: mechanistic studies of Pep-1 across DIBs
In my research, DIBs are used to study the mechanisms of Pep-1-mediated
enzyme translocation. In Chapter 2, I will describe DIB as a platform to study the
electrophysiological behavior of translocation and quantitate the amount of
transported horseradish peroxidase (HRP) across bilayers with the analysis by
fluorescence imaging. The quantitation method is applied to examine the function of
charged asymmetry DIB and reveals the role of negatively charged lipids on the
inner leaflet of membranes as a driving force for Pep-1. In Chapter 3, I will introduce
5

a flow-chip that enables reproducible perfusion of different solutions to a form DIB.
The flow-chip is combined with fluorescence microscopy to study membrane
transport, such as Pep-1-assisted HRP translocation. In Chapter 4, I will describe an
approach that allows the time-course observation of multiple transport events on a
dimple-chip. This approach has been used to study that the complex of Pep-1 and
cargo is crucial for translocation.
1.5 Reference
1. Morris, M. C., Deshayes, S., Heitz, F., and Divita, G. (2008) Cell-penetrating
peptides: from molecular mechanisms to therapeutics, Biol Cell 100, 201-217.
2. Grewer, C., Gameiro, A., Mager, T., and Fendler, K. (2013) Electrophysiological
characterization of membrane transport proteins, Annu Rev Biophys 42, 95-120.
3. Di Pisa, M., Chassaing, G., and Swiecicki, J. M. (2015) Translocation mechanism(s)
of cell-penetrating peptides: biophysical studies using artificial membrane bilayers,
Biochemistry 54, 194-207.
4. Holden, M. A., Needham, D., and Bayley, H. (2007) Functional bionetworks from
nanoliter water droplets, J. Am. Chem. Soc. 129, 8650-8655.
5. Bayley, H., Cronin, B., Heron, A., Holden, M. A., Hwang, W. L., Syeda, R., Thompson,
J., and Wallace, M. (2008) Droplet interface bilayers, Mol Biosyst 4, 1191-1208.
6. Hwang, W. L., Chen, M., Cronin, B., Holden, M. A., and Bayley, H. (2008)
Asymmetric droplet interface bilayers, J. Am. Chem. Soc.130, 5878-5879.
7. Hwang, W. L., Holden, M. A., White, S., and Bayley, H. (2007) Electrical behavior of
droplet interface bilayer networks: experimental analysis and modeling, J. Am.
Chem. Soc.129, 11854-11864.
8. Op den Kamp, J. A. (1979) Lipid asymmetry in membranes, Annu. Rev. Biochem. 48,
47-71.
9. Heron, A. J., Thompson, J. R., Cronin, B., Bayley, H., and Wallace, M. I. (2008)
Simultaneous measurement of ionic current and fluorescence from single protein
pores, J. Am. Chem. Soc. 131, 1652-1653.
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10. Castell, O. K., Berridge, J., and Wallace, M. I. (2012) Quantification of membrane
protein inhibition by optical ion flux in a droplet interface bilayer array, Angew
Chem Int Ed Engl 51, 3134-3138.
11. Deshayes, S., Morris, M. C., Divita, G., and Heitz, F. (2005) Cell-penetrating
peptides: tools for intracellular delivery of therapeutics, Cell Mol Life Sci 62, 18391849.
12. Prochiantz, A. (2008) Protein and peptide transduction, twenty years later a
happy birthday, Adv Drug Deliv Rev 60, 448-451.
13. Copolovici, D. M., Langel, K., Eriste, E., and Langel, U. (2014) Cell-penetrating
peptides: design, synthesis, and applications, ACS Nano 8, 1972-1994.
14. Hansen, M., Kilk, K., and Langel, U. (2008) Predicting cell-penetrating peptides,
Adv Drug Deliv Rev 60, 572-579.
15. Deshayes, S., Morris, M., Heitz, F., and Divita, G. (2008) Delivery of proteins and
nucleic acids using a non-covalent peptide-based strategy, Adv Drug Deliv Rev 60,
537-547.
16. Morris, M. C., Depollier, J., Mery, J., Heitz, F., and Divita, F. (2001) A peptide
carrier for the delivery of biologically active proteins into mammalian cells, Nat.
Biotechnol. 19, 1173-1176.
17. Gros, E., Deshayes, S., Morris, M. C., Aldrian-Herrada, G., Depollier, J., Heitz, F., and
Divita, G. (2006) A non-covalent peptide-based strategy for protein and peptide
nucleic acid transduction, Biochim. Biophys. Acta 1758, 384-393.
18. Henriques, S. T., Quintas, A., Bagatolli, L. A., Homble, F., and Castanho, M. A.
(2007) Energy-independent translocation of cell-penetrating peptides occurs
without formation of pores. A biophysical study with pep-1, Molecular membrane
biology 24, 282-293.
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CHAPTER 2
DIRECT QUANTIFICATION OF PEP-1-MEDIATED HORSERADISH
PEROXIDASE TRANSPORT ACROSS DIBs
2.1 Introduction
Cell penetrating peptides (CPPs) are a growing class of short cationic
peptides that deliver macromolecules into cells.

1, 2

Among the CPPs, Pep-1 is of

particular interest for its non-covalent interaction with cargo while most CPPs need
covalent crosslinking to the transported molecules.

3, 4

Pep-1 has demonstrated

great potential for therapeutic applications as it efficiently transports protein and
peptides in their biologically active form without perturbing the subcellular
localization of the cargo in the cells.

2, 3

The stability of Pep-1 in the physiological

buffer and the lack of toxicity of it also make it promising for cargo delivery across
cell membranes in vivo.

3

Pep-1 (Ac-KETWWETWWTEWSQPKKKRKV-cysteamine)

is an amphipathic peptide consisting of: (1) a hydrophobic tryptophan-rich domain,
which is crucial for interaction with cargo and hydrophobic core of membranes, (2)
a hydrophilic lysine-rich motif, responsible for solubility the peptide and nuclear
localization and (3) a space linker to improve the flexibility and integrity of the
hydrophobic and hydrophilic domains. 5
The mechanism of Pep-1-mediated transport at molecular level is not fully
understood and to gain deep insights into it is challenging. The conformational
structure of Pep-1 and the interaction between Pep-1 and membranes or lipids have
been extensively studied. 6-8 However investigations with Pep-1-delivered cargo are
infrequent. Morris et al. used Pep-1 to transport different cargoes to cell lines and
8

evaluated the efficiency by counting the number of transfected cells. 3 Henriques et
al. studied the Pep-1-mediated translocation of beta-Galactosidase (β-Gal) into
population of LUVs and measured the total delivered protein by the rate of
hydrolysis of the enzymatic substrate for β-Gal. 9 For a better understanding of the
mechanisms underlying cargo transportation assisted by Pep-1, a method to study
individual transport and quantitate the amount of delivered cargo is necessary.
In this chapter, we introduce DIBs as a well-suited technology for the
quantitation of individual translocation mediated by peptides. Here two lipidencased aqueous droplets are joined together to form bilayer at the interface. 10 As
an artificial lipid bilayer, the DIB enables precise controls of various factors, such as
bilayer composition and transmembrane potential. Asymmetry can be achieved
with DIBs easily, 11 which is essential to mimic biological environment of living cells.
Furthermore, the transported cargo from one droplet to the other one can be
isolated and studied individually. To quantitate the translocation, horseradish
peroxidase (HRP) is used as the protein cargo since its enzymatic activity can be
measured in a short period of time. Parts of these results have been published in the
Journal of the American Chemical Society (2011, 133, 15818-15821). 12

2.2 Results and discussions
We have demonstrated the method to quantitate the protein translocation
assisted by peptides based on the DIB technology (Figure 2.1). Here Pep-1 and HRP
were used as peptides and cargoes. Before each experiment the Pep-1/HRP
complexes were formed from the incubation between Pep-1 and HRP and then
9

mixed with vesicles to create a droplet. 3, 4 This droplet containing cargo or peptide
before translocation is named “source droplet”. Another blank droplet without any
protein or Pep-1, named “capture droplet”, was placed in the oil bath under the
working electrode on which potential is usually applied. The source droplet was set
on the grounded electrode in the same oil bath and moved to contact the capture
droplet to create a DIB for protein delivery. The two electrodes embedded in the
droplets allowed the application of potential and recorded the electrophysiological
measurements during translocation (Figure 2.2a). Following the translocation, the
capture droplet was separated from the source droplet and taken away from the
electrode with a pipette. It was fused with a droplet containing fluorogenic
substrate for HRP in buffer and measured by fluorescence microscopy after one
hour to quantitate the amount of transported HRP (Figure 2.2b). 13

Figure 2.1 Procedure of direct quantitation of enzyme transport across DIBs. Pep-1
and HRP are incubated to form complexes. After incubation, the complexes are
diluted with vesicles to create a source droplet. The source droplet is brought to
contact with a capture droplet to form a bilayer. The capture droplet is isolated after
45 min translocation and fused with a droplet containing fluorogenic substrate.
After one hour, the fused droplet is imaged by fluorescence microscopy to
quantitate the transported enzyme.
10

Figure 2.2 Methods to analyze the transport across DIBs. (a) The process of
translocation is monitored with electrophysiological recording. Bursts of ionic current
are detected when -50 mV is applied. (b) (c) Droplets with standards and the fused
droplet containing captured HRP and substrate are imaged by fluorescence microscopy.
(d) Fluorescence linescans of different droplets are plotted to calculate the
concentration of captured HRP. Reprinted with permission from J. Am. Chem. Soc. 133,
15818-15821. Copyright 2017 American Chemical Society.
We used the enzyme activity of HRP to quantitate the transported cargo
protein across lipid bilayers. In the fusion of capture droplet and fluorogenic
substrate droplet, HRP catalyzes the non-fluorescent substrate; Amplex Red, into a
highly fluorescent product, resorufin. 13 Droplets containing no HRP, 5pM HRP and
100 pM HRP was prepared as the background, standard and positive control to
show HRP’s enzymatic capability respectively. Each of these controls was fused with
a droplet of substrate. After one hour incubation with substrate on the depression
slides, all four droplets were imaged by a fluorescence microscope separately
(Figure 2.2c). After subtracting the background, the fluorescence of each droplet is
in linear relationship with the concentration of HRP (Figure 2. S1). Therefore the
11

amount of delivered HRP was calculated by comparing the fluorescence intensity
with that of 5pM HRP standard (Figure 2.2d).
Here we have shown the DIB is a power tool to investigate the mechanisms
with peptide-mediated cargo translocation. Previous research with quantitation and
large unilamellar vesicles (LUVs) involved populous vesicles and required the
removal of excessive nonincorporated Pep-1 and cargo proteins.9 However the DIB
allows the results of translocation to be isolated easily from the source of peptide
and cargo.10 Thus analysis of individual transport and quantitation of delivered
protein only is accessible with DIBs. Furthermore with the electrophysiology
coupled to quantitation, the ionic current is recorded and can be used for
correlation with translocation.

Figure 2.3 Effect of potential and ratio of Pep-1 to HRP on translocation. Each dot
shows the result from one experiment of 45 min transport. When -50mV was
applied across DIBs, more transported HRP was detected when using a 20:1 Pep-1to-HRP ratio (blue diamond dots) than a 10:1 ratio (green triangle dots). Little HRP
translocation was observed in the absence of either Pep-1(purple square dots) or
trans-membrane potential (orange round dots).
12

We next recapitulated the effect of potential on Pep-1 according to earlier
findings. Previous work has revealed that trans-membrane potential plays a crucial
role in the Pep-1 mediated translocation process.9, 14 Here we detected the HRP
transport assisted by Pep-1 across symmetric DIBs made of 100% 1,2-diphytanoylsn-glycero-3-phosphocholine (DPhPC, neutral) with potential. -50mV was applied
on the capture droplet when the DIB formed. When Pep-1 and HRP was incubated at
20:1 ratio, an average of 1.13pM HRP was transported across bilayers (Figure 2.3).
When the ratio of Pep-1 and HRP was 10:1, the transported cargo was greatly
reduced to an average of 0.26 pM (Figure 2.3). When using a 20:1 ratio, Pep-1
delivered very little HRP (Figure 2.3) without the application of potential. In the
absence of Pep-1 as the carrier, minimal HRP was observed in the capture droplet
(Figure 2.3). Therefore protein cargo does not cross bilayers by itself. Both Pep-1
and potential are essential for translocation. Previous investigation has indicated
that the ratio of Pep-1 and cargo affects the efficiency of translocation by counting
the number of transfected. 3, 4 Our work suggests that the ratio of carrier and cargo
directly affects the amount of transported cargo in individual translocation.
We then examined the effect of charge asymmetry on the Pep-1 assisted
protein translocation. Prior work of the interaction between Pep-1 and lipids has
shown that Pep-1 has a higher affinity to anionic lipids than neutral lipids.

5, 15-17

Henriques and co-workers suggest that translocation does not happen in symmetric
bilayer with negatively charged lipids and charge asymmetry is required by
investigating Pep-1 and vesicles.6 Here we made vesicles of 90 mol% DPhPC and 10
mol% 1,2-diphytanoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DPhPG, negative)
13

to form a droplet with negative charge.

DIBs were made with two different

monolayers, as one of them was neutral and the other was negative. Protein
transport was measured with a 20:1 Pep-1 to HRP ratio at 0 mV. When the capture
droplet was made of 10% DPhPG and 90% DPhPC, HRP was transported across the
bilayers by Pep-1. When the source droplet was made of the vesicles containing 10
mol% anionic lipids, very little HRP transport was observed. The capture droplet
mimics the inner leaflet of a living cell. The present work has revealed that the
charge asymmetry from anionic lipids of the inner leaflet plays a crucial role in the
Pep-1-mediated protein translocation. In certain mammalian cell membranes such
as platelet plasma membranes and erythrocyte membranes, the anionic
phosphatidylserine is exclusively on the cytoplasmic surface of the membranes
while the outer leaflet is made of neutral lipids.

18, 19

Thus the asymmetry of

negatively charged lipids of inner membrane leaflet may be a driving force in a
living cell.
We also studied the cargo translocation mediated by Pep-1 by
electrophysiological measurements. At -50mV discrete ionic bursts were observed
when using Pep-1/cargo complexes (Figure 2.2a) or Pep-1 only (Figure 2.S2a) in the
source droplet. The ionic current indicates the formation of transient pore structure
in the bilayers caused by Pep-1, as agrees with the previous results. 14, 20 Asymmetric
DIBs containing 10% negatively charged lipids in the capture droplet (Figure 2.2b)
led to the rupture of bilayers at a higher chance than symmetric DIBs of neutral
lipids. Pep-1/cargo complexes may form strong electrostatic interaction with the
negative charge on the inner membrane leaflet.
14

Figure 2.4 Effect of charge asymmetry on translocation. Potential was applied in
none of the trials. 10% PG with negative charge was added to one leaflet of the two
monolayers to create asymmetric DIBs. When negatively charged lipids were added
to the capture droplet ((a) left), HRP was transported across DIBs ((b) blue
diamond dots). When 10% PG was added to the source droplet ((a) right), minimal
translocation was observed ((b) orange round dots).

2.3 Conclusions
In this chapter, we have used DIBs to investigate the protein translocation
assisted by Pep-1. DIBs allow the electrophysiological recordings of the
translocation process and quantitation of the transported protein across bilayers.
The studies with the asymmetric DIB indicates that the negative charge in the inner
leaflet of cell membranes can work as a driving force for Pep-1 to deliver protein
across lipid bilayers. We anticipate that this approach will be exploited for
mechanistic studies of other cell penetrating peptides.
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2.4 Experimental methods
2.4.1 Reagents
Pep-1 was obtained from Activi Motif (Carlsband, CA). 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES) and sodium chloride (NaCl) were obtained
from Fisher Scientific. Hexadecane and low melting agarose were obtained from
Sigma-Aldrich. 1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC) and 1,2diphytanoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt) (DPhPG) were
purchased from Avanti Polar Lipids (Alabaster, AL). The protein cargo horseradish
peroxidase (HRP, peroxidase type XII from horseradish) was obtained from Fisher
Scientific. Amplex Red for the fluorogenic substrate was purchased Invitrogen.
Hydrogen peroxide (H2O2) was from Fisher Scientific.
2.4.2 Vesicles
In this chapter, all vesicles were prepared in 10 mM HEPES,150 mM NaCl pH
7.4 buffer. Vesicles were stored at 4°C for one-week use. DPhPC solution was stored
as 10 mg/mL stocks in pentane at -20 °C. After solvent evaporation by air stream,
lipids were moved to a vacuum desiccator for 30 min to achieve furthering drying.
Lipids were re-suspended in buffer for a final concentration of 2mM and this
mixture was extruded 21 times through a 100 nM filter (Millipore) to create
vesicles.
DPhPG solution was stored as 10 mg/mL stocks in chloroform at -20°C.
When preparing vesicle with negative lipids, DPhPC and DPhPG was mixed at a
molar ratio of 9:1 before solvent evaporation. The final concentration of total lipids
in vesicles was 2 mM.
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2.4.3 Incubation of Pep-1 and HRP to form complexes
Pep-1 was dissolved in 18 MΩ water to a 500 μM stock solution and was
stored as aliquots of 5 μL at -20°C. HRP was reconstituted in 18 MΩ water to a 50
μM stock solution and was stored as 10 μL aliquots at -20°C. Before each
translocation experiment using a 20:1 ratio of carrier and cargo, Pep-1 and HRP
were diluted in water from stock solutions to 40 μM and 2 μM, respectively. 10 μL of
each of these two dilutions were mixed and incubated for 30 min to form Pep1/HRP complexes at room temperature. Following incubation, 2 μL of complexes
were mixed with 18 μL vesicles for the solution to create the source droplet. The
final concentrations of Pep-1 and HRP in the source droplet were 2 μM and 100 nM,
respectively.
When using Pep-1/HRP of a 10:1 ratio, Pep-1 and HRP were diluted in water
to 20 μM and 2 μM, respectively. The remaining part of the procedure was the same
as described above.

Figure 2.5 Snake chip for translocation to avoid possible contamination. The
grounded electrodes with a capture droplet and the working electrode with a source
droplet are placed in separated reservoirs.
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2.4.4 Formation of DIBs and electrophysiological recording
To avoid possible contamination to the capture droplet from the tiny
droplets created when pipetting vesicles containing complexes into the oil, a special
“snake chip” with two parted wells (Figure 2.5) was designed as the oil reservoir for
the contamination experiments. First the snake chip was filled in with hexadecane.
Two Ag/AgCl electrodes coated with a thin layer of low melting agarose in buffer
were submerged into the wells, respectively (Figure 2.5). Each of the electrodes was
fixed to a micromanipulator to adjust the position through an alligator clip. The
other ends of the electrode were connected to a headstage. The headstage,
micromanipulators and oil reservois were placed in an enclosed metal box as a
Faraday cage. The source droplet of 200 nL vesicles containing Pep-1/HRP
complexes was pipetted onto the grounded electrode. The capture droplet of 200 nL
vesicles only was put on the working electrode, on which the potential was applied
(Figure 2.5). After the formation of monolayers, the source droplet was gently
moved to contact the capture droplet for creating a bilayer in the other well (Figure
2.5). Usually in less than a minute, bilayer formation was detected with an increase
in capacitance. The size of bilayer area was adjusted by controlling the
manipulators.
The two electrodes embedded in the droplets enabled application of
potential and electrophysiological recording across bilayers. These electrodes were
attached to an Axopatch 200Bamplifier (Axon Instruments). The signals were
filtered with filtered with a low-pass bessel filter (80 dB/decade) at a corner
frequencey of 2 kHz and next digitized with a DigiData 1400 series A/D converter
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(Axon Instruments) at 5 kHz. The electrophysiological data was analyzed with
Clampfit software.
2.4.5 HRP assay and fluorescence microscopy
Following translocation, the capture droplet was taken away from the source
droplet and fused with a 200nL buffer droplet of fluorogenic substrate containing
50 μM Amplex Red and 100 μM H2O2. HRP turns over the non-fluorescent Amplex
Red and H2O2 to highly fluorescent resorufin. In the fused droplet, the substrate for
HRP enzymatic activity was at non-limiting concentration. The fluorescence was
determined by the amount of captured HRP. After one hour, the relative
fluorescence (with background subtracted) is linear with the concentration of HRP
(Figure 2.S1). Together with the capture droplet, three control droplets were
prepared and fused with substrate. To eliminate the influence of the spontaneous
degradation of Amplex Red to resorufin, a 200 nL vesicle droplets was created as the
background for the relative fluorescence. A droplet containing 5 pM HRP in vesicles
was used as a standard to calculated the transported HRP in the capture droplet.
Another droplet of 100 pM HRP in vesicles was fused with substrate and showed the
capability of HRP catalysis with a fast production of resorufin. One hour after fusion
with substrate, each of the four droplets was imaged by fluorescence microscopy.
The maximum value of the linescan across the droplet was used as the fluorescence
intensity of the droplet. We subtracted the background from each droplet for the
relative fluorescence and compare that of the capture droplet with the 5pM to
quantitate the transported HRP.
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Each droplet was placed in a depression well with 2 mM DPhPC in
hexadecane for the fluorescence measurement. All droplets were imaged with a
Nikon Ti-u inverted fluorescence microscope using a Texas Red filter by a Cool
snapHQ2 digital camera by a Coolsnap HQ2 digital camera. The exposure time was
100 ms.
2.5 Supplementary information

Figure 2.S1 Calibration curve of the fluorescence and HRP in the droplet.
Fluorescence intensity (with background subtracted) is linear with the
concentration of HRP.
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Figure 2.S2 Electrophysiological recordings with -50mV applied across DIBs. (a)
Discrete bursts of ionic current were observed when only Pep-1 exited in the source
droplet without protein cargo on a symmetric DIB made of 100%PC. (b) When 10%
DPhPG was added to the capture droplet to form an asymmetric DIB, the bilayer was
more likely to rupture.
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CHAPTER 3
REREPEATED ADDITION AND REMOVAL OF REAGENTS ON DROPLETINTERFACE BILAYERS
3.1 Introduction
The droplet-interface bilayer (DIB) is a promising tool for the mechanistic
studies of membrane transport.

1-3

A DIB is easily created with two lipid-encased

aqueous droplets joined together in the oil bath and the monolayers contact to form
a bilayer at the interface. 2 The limitation of DIBs is that the droplet is enclosed and
the inner component cannot be changed.
Previous studies have attempted to alter the membrane composition on the
droplet-based artificial bilayer. Thompson et al. ejected protein into the droplet,
which formed a bilayer with lipid-coated hydrogel, by a nano-injection capillary.

4

The volume injected should be relatively tiny in order to protect the bilayer from
rupture. Mixing the solution within the droplet was inaccessible so that the addition
might lead to uneven distribution of reagents. 4, 5 El-Arabi et al. performed solution
exchange through a channel under the bilayer by addition and withdraw through
the fluid inlet and outlet. 6 The channel was large with 200 μL and complete solution
exchange was not achieved. 6 Tsuji et al. developed a perfusion system based on DIB
and the solution of one droplet can be exchanged via a fluidic channel underneath
the droplet. 7 However this approach can’t make continuous addition and removal of
solution.
In this chapter we build new flow-chip that allows repeated perfusion to a
formed DIB. We demonstrate the capability of solution exchange by α-hemolysin
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(αHL) and its blocker cyclodextrin (γCD). And then we use the flow-chip to study the
translocation of horseradish peroxidase (HRP) assisted by Pep-1, a cell penetrating
peptide. Parts of these results have been published on the Lab on a Chip (2013, 13,
2749-2753). 8

3.2 Results and discussions
We have designed a flow-chip for repeated solution exchange on the DIB.
Here the DIB was formed between an aqueous dome on top of a glass capillary and a
movable droplet hanging from the working electrode. The glass capillary was
fabricated for perfusion of different reagents. Four fused silica Microfil capillaries
(26 gauge, World Precision) were glued (Epoxy) as a bundle. The bundle was then
placed inside the 1 cm-long glass capillary (1mm diameter) and fixed at 1 mm below
the top of the glass capillary by glue. The glass capillary was inserted to the oil
reservoir from the bottom (Figure 3.1). The other end of each Microfil capillaries
was attached to a female Luer-Lok fitting, which was connected to a 500 μL gas tight
syringe (Hamilton). Two of the syringes were combined to a modified pump in the
opposite orientations. Of them the syringe responsible for infusion was filled in with
the solution while the one for withdrawal was loaded with buffer. Thus the pump
could infuse a solution to the aqueous dome and withdraw solution from it at an
identical rate. The remaining two syringes were connected to a second pump in the
same method. We used the flow-chip to remove dye solution from the aqueous
dome via the perfusion of buffer and showed that the flow didn’t alter the DIB area
(Figure 3.S1).
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Figure 3.1 Fabrication of flow-chip. Four microfil capillaries are glued together and
inside the top end of a glass capillary. An aqueous dome of vesicles is placed above
the glass capillary to form a bilayer with a movable droplet from the working
electrode. The other end of each microfil capillary is connected to a syringe. One
programmable pump controls two syringes to perfuse one solution (buffer).
Another pump manages the remaining two syringes to perfuse a different solution
(g-CD). Reproduced from Lab Chip 13, 2749-2753 by permission from The Royal
Society of Chemistry.
The DIB apparatus, including the oil reservoir, was encircled in a metal box
as the Faraday cage. Pumps were placed outside the box. The glass capillary was
arranged inside the box from the bottom through a hole on the base of it. It was
crucial to put the grounded electrode in the aqueous dome to eliminate electrical
noises from the pumps (Figure 3.1). As a proof of concept, I have demonstrated the
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flow-chip with αHL and its non-covalent blocker γCD for repeated addition and
removal. 1 μL vesicles in 10mM HEPES, 1 M KCl , pH 7.4 buffer was placed on top of
the glass capillary to create an aqueous dome. A 200 nL droplet containing 10 nM
αHL was hang from the working electrode and moved to the aqueous dome for
bilayer formation after the stabilization of monolayers (Figure 3.S2). The insertion
of a single pore of αHL was observed at -50 mV from the electrical recording at the
beginning (Figure 3.2a). Then the dome was perfused with 50 μM γCD in buffer at a
flow rate of 1 μLs-1 for 10 s. In less than 5s after the start of the addition of it, γCD
was observed with transient partial blockades in ionic current. Next the dome was
perfused with buffer for 20 s to remove the blocker. γCD was completely eliminated
from the dome as the reversible blocking events faded. The circle of addition and
removal was repeated for another three times (Figure 3.2).

Figure 3.2 Demonstration of solution exchange by αHL and gCD.
Electrophysiological recording was performed on a single pore of αHL at -50mV. (a)
Four continuous cycles of addition (blue bars) of gCD to α-HL and complete removal
(red bars) were proved by the appearances and disappearances of blocking events.
(b) and (c): The addition and removal of the third cycle were expanded. Adapted
from Lab Chip 13, 2749-2753 by permission from The Royal Society of Chemistry.
Here I have shown that the flow-chip enables repeated addition and removal
of different reagents to a formed DIB. The bilayer is stable during the perfusion. The
solution exchange is rapid as smaller volume is used compared with in other
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systems and the whole volume of the perfused dome could be perfused in 1 second.
Mixing of the solution is not required and the concentration of the reagents in the
perfused dome is known and under control. Our approach has greatly reduced
stagnation in the channel since the flow is almost orthogonal to the bilayer area
while other methods used parallel flow of solution to the membrane.

Figure3. 3 Peptide-assisted protein translocation on the flow device. Complexes
between Pep-1 and HRP in buffer were perfused to bilayer for 20 seconds. More
HRP transport was observed in the movable droplet when using 45 min for
translocation following perfusion than using 10 min.
I next combined the flow-chip with fluorescence microscopy for studies of
membrane transport across lipid bilayers. In Chapter 2, we have applied DIB
technology coupled with fluorescence measurement to quantitate the transport of a
protein cargo HRP mediated by Pep-1, a cell penetrating peptide. 3 In the previous
work, the complexes of incubated Pep-1 and HRP were mixed with vesicles before
the formation of lipid bilayer. It is possible that the Pep-1/HRP complexes interact
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with vesicles and are adsorbed on to the oil-water interface before the stabilization
of the monolayer to interfere with the transport. Therefore to load Pep-1/HRP to an
established bilayer is essential for the mechanistic investigations of translocation.
Here I created a DIB between the aqueous dome and the movable droplet
from only vesicles. After the incubation of Pep-1 and HRP, the complex was diluted
with buffer (10 mM HEPES, 150 mM NaCl, pH7.4) and perfused to the aqueous dome
for 20 s. A voltage of -50 mV was applied to drive the translocation. After 45 min,
the movable droplet was separated from the aqueous dome and was moved out of
the oil reservoir for fluorescence measurements. An average of 3.36 pM transported
HRP was observed. The present work has demonstrated that the captured HRP is
from translocation across lipid bilayer rather than from the adsorption of Pep1/HRP complexes to the oil-water interface. More transported HRP was observed in
the flow-chip than in the enclosed DIB. 3 In the flow-chip, the excessive vesicles that
were not forming a monolayer were removed with the perfusion of Pep-1/HRP
complexes while the complex was mixed with vesicles in the enclosed DIB. We are
working on the effect of vesicles on the peptide-assisted translocation. When the
period of translocation was 10 min, the captured HRP in the movable droplet was
reduced to 0.82 pM averagely (Figure 3.3). Our work indicates the cargo transport
mediated by Pep-1 is dependent of time.

3.3 Conclusions
Here we have developed a flow-chip for repeated addition and removal of
different solutions to a DIB. Application of this device on Pep-1-mediated HRP
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transport reveals that the translocation process is time-dependent. We will use the
flow-chip to study the translocation of protein to a bilayer loaded with Pep-1. The
flow-chip has great potential for ionic channel screening with the capability of rapid
solution exchange.

3.4 Experimental methods
3.4.1 Reagents
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), potassium
chloride (KCl), potassium hydroxide (KOH), sodium chloride (NaCl) and sodium
hydroxide (NaOH) were obtained from Fisher Scientific. Hexadecane and low
melting agarose were obtained from Sigma-Aldrich. 1,2-diphytanoyl-sn-glycero-3phosphocholine (DPhPC) was purchased from Avanti Polar Lipids (Alabaster, AL). αhemolysin (αHL) was from James Clake of Oxford Nanopore Technologies Ltd. γ–
cyclodextrin (γCD) was purchased from Sigma-Aldrich. Pep-1 was obtained from
Activi Motif (Carlsband, CA). Horseradish peroxidase (HRP, peroxidase type XII from
horseradish) was obtained from Fisher Scientific. Amplex Red for the fluorogenic
substrate was purchased Invitrogen. Hydrogen peroxide (H2O2) was from Fisher
Scientific.
3.4.2 Vesicles
In this chapter, all vesicles were prepared as 2mM DPhPC in buffer. Vesicles
were stored at 4°C for one-week use. For the demonstration of flow-chip with αHL
and γCD, the buffer was 10 mM HEPES, 1 M KCl, pH7.4. For the transport
experiment by Pep-1 and HRP, the buffer was 10 mM HEPES, 150 mM NaCl, pH7.4.
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The detailed procedure to prepare vesicles by extrusion was described in Section
2.4.2.
3.4.3 Incubation of Pep-1 and HRP for complexes
Equal volumes of 40 μM Pep-1 and 2 μM HRP were mixed and incubated for
30 min to form complexes at room temperature. After the incubation, the complexes
were diluted with buffer to a final concentration of Pep-1 and HRP at 2 μM and 100
nM, respectively.
3.4.4 HRP assay and fluorescence microscopy
The movable droplet with captured HRP was separated from the aqueous
dome and taken out of the oil. It was then fused with the fluorogenic substrate for
quantitation of HRP transported by Pep-1. The details of fluorescence measurement
and data analysis are described in section 2.4.4.
3.5 Supplementary information

Figure 3.S1 Removal of dye from a DIB. The orthogonal flow of buffer to the bilayer
removed dye solution in the aqueous dome without changing the size of bilayer. The
grounded electrode was buried with the bundle of Microfil capillaries.
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Figure 3.S2 Bright-field image of flow device. Lipid bilayer forms between an
aqueous dome and a movable droplet. Adapted from Lab Chip 13, 2749-2753 by
permission from The Royal Society of Chemistry.
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CHAPTER 4
TIME-LAPSE FLUORESCENCE DETECTION OF PROTEIN TRANSLOCATION
ON MULTIPLE MEMBRANES
4.1 Introduction
In our group, we have used the droplet-interface bilayer (DIB) technology to
study the mechanism of protein transport mediated by an efficient cell-penetrating
peptide (CPP), Pep-1.1 This approach allows recordings of electrical behavior and
direct quantitation of a single translocation event across the artificial bilayer.1 The
DIB has shown a high potential to investigate the molecular mechanisms of CPPs
traversing cell membranes. The capability of using DIBs to evaluate the
translocation efficiency by quantitative analysis of cargo uptake is advantageous in
providing information for designing and predicting new CPPs.2 We have applied the
method to examine the effect of charged asymmetric bilayers on Pep-1-mediated
protein translocation and have shown that the negative charge on the inner leaflet
of cell membranes can work as a driving force for Pep-1 to carry cargo into cells.1 To
gain a deeper insight of the function of negative charge, we need to perform futher
studies, such as the effect of different percentage of negative charge, different types
of negatively charged lipids and proteins with different properties. It is timeconsuming as the previous DIB method can only analyze single membrane transport
event in an experiment.1, 3 Thus, it would be highly desirable to develop a productive
method that enables parallel observations of translocation events on multiple
individual DIBs.
When investigating membrane transport, the technique of creating droplet
arrays has been introduced to DIBs to increase productivity.4-6 Syeda et al. created
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DIBs between a movable droplet with ion channel and an array of droplets
containing different blockers on wells, which can be used for screening. 4 Castell et
al. built an array of multiple bilayers formed between aqueous droplets and a
hydrogel bottom surface in lipid/oil mixture.5 Tonooka et al. described a method to
form DIBs between an array of picoliter-sized semispherical droplets and one upper
large aqueous droplet.6 In both methods, fluorescence microscopy recorded the
ionic flux through transmembrane pores on bilayers.5, 6 The time-course of the
membrane transport of ions could be traced.
In Chapter 2, the process of the membrane transport assisted by CPPs was
observed with electrophysiological measurements and the result suggests the
formation of transmembrane pore-like structures by Pep-1.1 However the process of
the cargo translocation was not monitored quantitatively. Here, we have used a
“dimple-chip” with micromachined indentations (dimples) to arrange discrete DIBs
for direct quantitation of multiple membrane transport events and introduced timelapse fluorescence microscopy to record the time-course of protein translocation.
The substrate for enzyme cargo is placed in one of the droplet and the
peptide/cargo complexes are in the other droplet, so that the transported cargo can
be detected by fluorescence imaging soon after it crosses the DIB.
We used Pep-1 and β-galactosidase (β-Gal) as the carrier and cargo for the
proof-of-concept studies and investigated the mechanism of membrane transport by
Pep-1 across multiple DIBs on the dimple-chip. Pep-1 is a promising CPP for its
therapeutic applications due to the high efficiency of transport and the lack of
toxicity.7-9 It binds to proteins and peptides non-covalently and delivers them into
34

cells in their fully biologically active form.7 The enzyme β-Gal is a homotetramer
that hydrolyzes β-D-galactopyranoside with a glycosidic bond.10-12 Pep-1 can
transport β-Gal into different cell lines.7, 11 In this chapter β-Gal is detected and
quantified via its enzymatic activity by fluorescence imaging. We first recapitulate
the previous conclusion of the function of charge asymmetry on translocation and
then examine the effect of formation of carrier/cargo complexes.

4.2 Results and discussions
We created a dimple-chip with a square array of multiple micromachined
indentations on the bottom surface. The well of the dimple-chip was filled with
hexadecane (HD) and the lipid-encased droplets were created from the vesicles
inside the droplets (“lipid-in” technique). Each dimple can support one monolayerencased droplet and two adjacent droplets were brought to contact for forming a
bilayer. Each DIB was composed of a source droplet containing Pep-1/β-Gal
complexes and a capture droplet containing excess substrate resorufin-β-Dgalactopyranoside (RG) for β-Gal detection. At most， 16 discrete DIBs can be
created on a dimple-chip (Figure 2.1a). The DIBs on a dimple-chip can consist of
different components because the compositions of the droplets are determined by
the inner contents.
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Figure 4. 1 Real-time detection and quantification of peptide assisted enzyme
translocation. (a) A source droplet containing Pep-1/β-Gal complexes and vesicles
and a capture droplet containing fluorogenic substrate and vesicles form a DIB in
the dimple-chip. Multiple DIBs are arranged on the dimples. The enzyme
transported across DIB converts the substrate RG into fluorescent resorufin. The
time-course of translocation process is traced by time-lapse fluorescence
microscopy. (b) Fluorescence intensity of the capture droplet is plotted against
time. The droplets are imaged at 2 min interval. The intensity increase when protein
is transported (blue dots) across the bilayer and it doesn’t change much when there
is no translocation (orange dots). Once the translocation ceases, the fluorescence
intensity is linear with time. The slope of this line is used to quantitate the delivered
enzyme in the capture droplet.
Time-lapse fluorescence microscopy was used to observe the process of
transport across DIBs as soon as the droplets contact. The dimple-chip was placed
above the objective lens of a fluorescence microscope for time-lapse imaging. In my
experiments, four droplets could be imaged simultaneously. When translocation
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across a DIB occurred, the delivered β-Gal catalyzed the hydrolysis of RG to the
highly fluorescent resorufin and the fluorescence intensity increased with time
(Figure 4.1b, blue dots). When no β-Gal was transported to the capture droplet,
minimal change of fluorescence was observed (Figure 4.1b, orange dots).
On the plot of fluorescence intensity against time, the slope of the curve at
each point stood for the rate of the hydrolysis of RG. The rate was proportional to
the concentration of β-Gal in the capture droplet because of the excess RG as a
substrate. We have demonstrated that the slope of fluorescence intensity against
time is in a linear relationship with the concentration of β-Gal in the droplets
(Figure 4.S1). Therefore, the change of the slope worked as a real-time observation
of cargo transport. In the end the fluorescence intensity formed a linear relationship
with time and the slope was a constant from 100 min to 120 min (Figure 4.1b). This
slope of the capture β-Gal was compared with that of a standard droplet containing
1 pM β-Gal to calculate the amount of transported cargo.
As a proof of concept, we first examined the function of negative charge
asymmetry across DIB as a driving force for Pep-1-assisted β-Gal translocation. We
have studied the translocation of horseradish peroxidase (HRP) mediated by Pep-1
across an asymmetric DIB consisting of a negatively charged leaflet and a neutral
leaflet.1 Our results show that the cargo translocation occurs when the complex of
Pep-1/HRP is placed in the neutral side while no protein translocation is observed
when it is in the negative side. Here, we monitored the β-Gal translocation by Pep-1
under the conditions of symmetric and asymmetric DIB simultaneously and make
direct comparison of the results.
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Figure 4. 2 Effect of charge asymmetry across bilayer on translocation.
Transported β-Gal of each DIB is represented as a dot. The dots on the same x value
were done simultaneously for direct comparisons. When asymmetric DIB was
created with 30% negatively charged lipids in the capture droplets ((b) top), β-Gal
translocation was detected ((a) blue square dots). No translocation was observed
on the symmetric DIB ((a) orange square dots, (b) bottom.).
A symmetric DIB and a charged asymmetric DIB were created on the dimplechip. The symmetric DIB consisted of 1,2-diphytanoyl-sn-glycero-3-phosphocholine
(DPhPC, neutral). The neutral source droplet of the asymmetric DIB was composed
of pure DPhPC, while the negative capture droplet of it was 70% DPhPC and 30%
1,2-diphytanoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt) (DPhPG,
negative) (Figure 2.2b). Before each translocation experiment, 300 μL capture
droplets containing RG were placed on the dimple. Pep-1 and β-Gal at a ratio of 80:1
were mixed and incubated for 30 min to form complexes. The complexes were
mixed with vesicles to create source droplets. The 300 μL source droplets were
placed close to capture droplets and rolled to form DIBs. Translocation of β-Gal was
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observed on the asymmetric DIB with 30% negatively charged lipids in the capture
droplet (Figure 4.2a). Very little translocation was detected across the symmetric
DIB of neutral lipids (Figure 4.2a).
We performed control experiments in the absence of Pep-1. The result has
shown that the β-Gal does not traverse asymmetric bilayers without the assistance
of carriers (Figure 4.S2). When the Pep-1/β-Gal was in the negative side with 30%
DPhPG of the charged asymmetric DIB, minimal protein transport was observed
(Figure 4.S3).
We have developed a method to monitor and quantitate membrane transport
across multiple DIBs. For the intrinsic properties of DIBs, this method is
advantageous for direct quantitation of single event of membrane transport without
the wash-out of excess peptide/protein complexes which do not cross the bilayer.
Furthermore, productivity is greatly increased with simultaneous measurements of
multiple bilayers. Here, the quantitation of transported β-Gal does not require
separation of the DIB because the capture droplet contains substrate for enzymatic
activity. It avoids possible contamination from droplet detachment. Time-lapse
fluorescence imaging allows real-time detection of the course of membrane
transport. As the droplet composition is determined by the inner content, DIBs can
be created for different circumstances on the same chip. Therefore, we can compare
membrane transport under different conditions concurrently.
Our previous research has indicated that negative charge asymmetry facing
away from the complexes drives Pep-1-mediated translocation of HRP across DIBs.1
Here, the presence of negatively charged lipids in the capture droplet also promotes
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the transport of β-Gal, which is much larger than HRP. β-Gal has been delivered to
different cell lines with the assistance of Pep-1.7, 11 Therefore our results suggest
that the negative charge on the cytoplasmic surface of cell membranes is the driving
force in the living cells. It implies that the electrostatic force between negatively
charged inner leaflet and positively charged peptide/cargo complexes drives the
translocation.
The time-course of protein transport across bilayers was traced by timelapse fluorescence measurements (Figure 4.1b). On the curve of fluorescence
intensity as a function of time, the slope at each point is the rate of the catalysis of
enzyme substrate, determined by the amount of transported protein. The curve
indicates that Pep-1-mediated β-Gal translocation does not start as soon as the
bilayer forms. Protein cargo is transported across the DIB gradually after a time
threshold as the slope of each point is increasing. The translocation eventually
ceased by itself and the slope became constant; within 2 h under the condition we
applied.
We next investigated whether complex formation between carrier and cargo
is crucial for transport across DIBs. The formation of complexes of Pep-1 and
different proteins/peptides has been verified with various methods, such as sizeexclusion chromatography, dynamic light scattering (DLS) and scanning electron
microscopy (SEM).7, 8, 13 The size of the complex is related to the ratio of Pep-1 and
cargo, which in turns affects the transfection efficiency.7, 13 The conformational
change of free Pep-1 has been studied extensively. In water, Pep-1 tranforms from
random coils to α-helical structures of residues 4-13 with an increase of
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concentration.14-16 In my experiment, Pep-1 (final concentration 2 μM) is in a
nonstructured conformation. Pep-1 interacts with phospholipids and induces
formation of α-helical structures.15 The conformation of Pep-1 is not altered by the
addition of cargo peptides.15 The electrical behavior of Pep-1 in artificial bilayers
indicates pore formation in the absence of cargo.1, 17 It is of particular interest
whether cargo can cross bilayers through the pore induced by Pep-1 without
forming complexes.

Figure 4. 3 Effect of incubation of Pep-1 and β-Gal. The dots on the same x value
were done simultaneously for direct comparisons. More translocation was detected
when utilizing pep-1 and β-Gal complexes with 30 min incubation ((a) blue round
dots, (b) top) than free pep-1 and β-Gal without incubation ((a) red square dots, (b)
bottom).
In previous experiments, Pep-1 and cargo were incubated for 30 min to form
complexes. We then examined the effect of Pep-1 and β-Gal incubation. We set two
charged asymmetric DIBs on the dimple-chip (Figure 4.3b). Both DIBs were
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composed of a source droplet with pure DPhPC and a capture droplet with 30%
DPhPG and 70% DPhPC. Pep-1 and β-Gal were incubated for 30 min and mixed with
vesicles to form one source droplet. To create the other source droplet, Pep-1 and βGal was mixed and soon diluted with vesicles without incubation (Figure 4.3b).
More β-Gal transported across DIB was observed when using Pep-1 and protein
with incubation than without incubation (Figure 4.3a).
Here, we compare β-Gal translocation mediated by Pep-1 under the condition
with or without incubation. The amount of transported β-Gal was greatly reduced
when Pep-1 and β-Gal was not incubated. This result indicates free protein cargo
cannot traverse the pore structures induced by Pep-1. We still observed
translocation when using Pep-1 and β-Gal without incubation. It is because Pep-1
and β-Gal start forming complexes as soon as they are mixed. My research fellow,
Xin Li, has used DLS to detect fast association of Pep-1 and β-Gal (data not shown).
Our result implies that the assembly of Pep-1 and protein cargo is essential for
translocation.

4.3 Conclusions
In this chapter, we have demonstrated a new method with great potential to
study membrane transport across multiple DIBs simultaneously on a dimple-chip.
This approach allows time-lapse recording and quantitation of membrane transport.
The effect of different conditions can be observed and compared directly. We used
this approach to study β-Gal translocation mediated by Pep-1. Our results indicate
that the electrostatic force between the Pep-1/cargo complexes and the negative
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charge on the inner leaflet can drive translocation and it is crucial for the cargo to be
in the complex form with Pep-1.
We anticipate that the approach may be exploited to gain insights into the
molecular mechanisms of Pep-1 and other CPPs by examining other factors. To
increase further the productivity, automation method to create droplets and widefield microscopy are required to observe a large array of DIBs. Microfluidic methods
have been used to form interconnected DIBs,18-22 which pumps oil and aqueous
solution into the tubing alternatively to create droplets.18 The size of the droplet
created ranges from nanoliter to milliliter.18, 20 Designed chambers are used to
control the position of the droplet for the DIB arrays.19, 21 Microfluidic methods
enable the formation of asymmetric DIB and fluorescence measurement.18, 22 In the
future, we will combine the microfluidic methods with the DIB technology to study
membrane transport across multiple membranes.

4.4 Experimental methods
4.4.1 Reagents
Pep-1(Ac-KETWWETWWTEWSQPKKKRKV-cysteamine) was obtained from
Active Motif (Carlsbad, CA). 1,2-Diphytanoyl-sn-glycero-3-phosphocholine (DPhPC)
and 1,2-diphytanoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (sodium salt) (DPhPG)
were purchased from Avanti Polar Lipids (Alabaster, AL). Hexadecane and low
melting agarose were obtained from Sigma-Aldrich. 4-(2-Hydroxyethyl)-1piperazineethanesulfonic acid (HEPES) and sodium chloride (NaCl) were obtained
from Fisher Scientific. The protein cargo β-galactosidase (β-Gal) was obtained from
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Sigma-Aldrich. The fluorogenic substrate resorufin-β-D-galactopyranoside (RG) was
purchased from Invitrogen.
4.4.2 Vesicles
In this chapter, all vesicles were prepared in 10 mM HEPES, 150 mM NaCl, pH
7.4 buffer. Vesicles were stored at 4 °C for one-week use. DPhPC solution was dried
and the lipids were resuspended in buffer for a final concentration of 2.5 mM and
this mixture was extruded 21 times through a 100 nm filter (Millipore) to create
vesicles. When preparing vesicles for the leaflet with negative charge, DPhPC and
DPhPG were mixed at a mole ratio of 7:3 before solvent evaporation. The final
concentration of total lipids in the vesicles was 2.5 mM.
4.4.3 Incubation of Pep-1 and β-Gal to form complexes
Pep-1 was dissolved in 18 MΩ water to a 680 μM stock solution and was
stored as aliquots of 5 μL at –20°C. β-Gal was reconstituted and stored as 10 μL
aliquots at -20°C. Before each translocation experiment (except the condition
without incubation), Pep-1 and β-Gal were diluted in water from stock solutions to
40 μM and 500 nM, respectively. Ten microliters of each of these two dilutions were
mixed and incubated for 30 min to form Pep-1/β-Gal complexes at room
temperature. Following incubation, 2 μL of the product containing complexes were
mixed with 18 μL vesicles to create the solution for the source droplet. The final
concentrations of Pep-1 and β-Gal in the source droplet were 2 μM and 25 nM,
respectively.
When using Pep-1 and β-Gal without incubation, 10 μL of 40 μM Pep-1 and
10 μL of 500 nM β-Gal were first kept at room temperature for 30 min separately
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when the other set was under incubation. These two solutions were then mixed and
immediately diluted with vesicles right before the creation of the bilayer.
4.4.4 Formation of DIBs on dimple-chip
RG powder was reconstituted in 18 MΩ water to a 50 mM stock solution and
stored at –20 °C. 50 mM RG stock solution was diluted with water to 500 μM. Two
microliters of 500 μM was mixed with 18 μL vesicles. We used 300 nL of this
dilution and pipetted it into oil to create a capture droplet containing 50 μM RG. The
monolayer was stabilized via immerging droplets in HD with lipids. Capture
droplets were placed on dimples and then source droplets containing protein were
put on the dimple with one blank dimple away from the capture one. The source
droplet was rolled on the dimple next to the capture droplet for bilayer formation.
The droplets were kept in contact for 2 h in the translocation experiment.
4.4.5 Time-lapse fluorescence microscopy and β-Gal quantitation
All droplets were imaged with a Nikon Ti-u inverted fluorescence microscope
using a Texas Red filter by a Coolsnap HQ2 digital camera. The exposure time was
200 ms. Droplets were imaged at an interval of 2 min for 2 h since they were
brought into contact. A standard droplet (300 nL) containing 1pM β-Gal and 50 μM
RG was prepared on the dimple-chip and the fluorescence intensity was measured
at 2 min intervals. The slope of captured β-Gal was calculated based on the data
between 100 min and 120 min of the graph of fluorescence intensity against time.
We compared it with the slope of 1pM β-Gal to calculate the concentration.
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4.5 Supplementary information

fluorescence =
slope  time + b

Figure 4. S1 Calculation of transported β-Gal in a droplet. (a) Fluorescence intensity
of a droplet containing 1 pM β-Gal and 50 μM substrate is in a linear relationship
with time (blue round dots). The slope of the line stands for the rate at which β-Gal
catalyzes substrate to fluorescent product. Fluorescence of a droplet containing
substrate only shows minimal change with time (orange square dots). (b)
Calibration curve shows that the slope is linear with the concentration β-Gal in the
droplet.
Before we studied β-Gal translocation across DIB, we first demonstrated that
the fluorescence intensity is linear with time in the droplet containing a certain
amount of β-Gal and substrate (Figure 4.S1a). We created a droplet containing 1 pM
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β-Gal and 50 μM RG and measured the fluorescence intensity at an interval of 2 min
(Figure 4.S1a). The linearity was maintained for at least 12 h. The slope of the line is
in a linear relationship with the concentration of β-Gal in the droplets (Figure 4.S1b).

Figure 4.S2 β-Gal translocation control experiments in the absence of Pep-1. (a) βGal translocation across DIB was studied in the absence of Pep-1 on asymmetric
DIBs with negatively charged lipids in the capture droplet. (b) The fluorescence
intensity of the capture droplet decreased 2 hours after the contact of droplets when
there was no Pep-1 in the source droplet, as indicates no β-Gal is found in the
capture droplet.
We studied the protein translocation on charged asymmetric DIB in the
absence of Pep-1. We created multiple DIBs on the dimple-chip. Each DIB was
composed of a source droplet containing β-Gal, which was made of pure DPhPC, and
a capture droplet containing RG, which was made of 30% DPhPG and 70% DPhPC
(Figure 4.S2a). Each DIB was kept in contact for 2 hours. The fluorescence intensity
of the capture droplets was measured when the droplets were attached and 2 h
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after attachment. The decrease of the fluorescence intensity suggests that no β-Gal is
observed in the capture droplet (Figure 4.S2b). The decrease in fluorescence may
result from the diffusion of resorufin, from the self-turnover of RG in the capture
droplet, to the source droplet. Thus, negatively charged lipids cannot promote
protein transport without the support of Pep-1.

Figure 4. S3 Effect of the orientation of charged asymmetric DIB on translocation.
Minimal turnover of fluorogenic substrate was observed after 120min when Pep-1/
β-Gal complex was put in the negative side of the asymmetric DIB. ((a) and (c). The
transported β-Gal was detected in the asymmetric DIBs when Pep-1/ β-Gal complex
was placed in the neutral side ((b) and (d).
We tested β-Gal transport across asymmetric DIB when Pep-1/β-Gal complex
was in the same leaflet with negatively charged lipids. Four asymmetric DIBs were
formed on the dimple-chip, each of which consisted of a neutral leaflet and a
negatively charged leaflet with 30% DPhPG and 70% DPhPC. Two of these DIBs had
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Pep-1/β-Gal complex in the negative side of the charged asymmetric DIBs (Figure
4.S3a). The other two have the complex in the neutral side (Figure 4.S3b), which
worked as positive controls to demonstrate the capability of Pep-1-assisted delivery
of β-Gal (Figure 4.S3d). All of the capture droplets were imaged with a fluorescence
microscope upon contact of DIB and 2 h later. When placing Pep-1/β-Gal in the
negatively charged leaflet, the change of the fluorescence intensity was small and to
the same extent as that of the self-turnover of RG (Figure 4.S3c). Therefore negative
charge can only drive Pep-1-mediated β-Gal translocation when in the leaflet facing
away from the complex.
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CHAPTER 5
CONCLUSIONS AND FUTURE WORK
5.1 Conclusions
We have applied DIB as a platform and develop its function for the
mechanistic studies of membrane transport assisted by Pep-1. DIB technologies
enable the quantitation of peptide-assisted translocation, repeated perfusion of
different reagents to a formed bilayer and observation of time-courses of membrane
transport on multiple membranes.
Our results strongly suggest that the negative charge on the cytoplasmic
surface of the cell membrane is a driving force for the cargo transport mediated by
Pep-1.1 Electrophysiological recording during the translocation process indicates
the formation of pore structures induced by Pep-1, which agrees with the previous
research.1, 2 Further studies have shown that the amount of transported cargo is
time-dependent. Investigation of Pep-1/protein incubation indicates the formation
of carrier/cargo complex is crucial for translocation.

Previous research has

suggested the presence of free Pep-1 with Pep-1/cargo complexes after incubation.3
Here, we propose a mode for Pep-1-assisted protein translocation across
membranes: free Pep-1 interacts with lipids and form pore structures in the
bilayers; the electrostatic force between negatively charged lipids and positively
charged Pep-1/protein complexes drives the translocation of protein through the
pore induced by Pep-1.
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Figure 5. 1 Proposed mode of action. (a) The interaction between Pep-1 and
membrane is mainly dependent on the hydrophobic force. (b) and (c) The
electrostatic interaction between the inner leaflet and Pep-1-cargo complexes are
required for translocation.
5.2 Future work
The function of phosphatidylserine (PS) on Pep-1-mediated protein
translocation will be investigated because it is a negatively charged lipid with
biological relevance. Our data has shown the significance of electrostatic force in
driving the transport. The effect of ionic strength on Pep-1-cargo binding and the
interaction between Pep-1 and bilayers will be studied. Mass spectrometry has
shown that Pep-1 can form dimer through the disulfide bond. Henriques et al.
indicated that Pep-1 dimer could be driven from bilayer to the reducing nonlipidic
solution.4 The effect of reducing environment can be studied on a flow-chip where
the reducing and oxidizing solution can be exchanged across a bilayer. The timecourse of Pep-1-assisted β-galactosidase translocation has shown that the process
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ceases by itself. It is of great importance to understand the factor that regulates the
time of the length of the translocation to control the amount of delivered cargo.
We have developed DIB with novel functions, which also make contribution
to research other than cell-penetrating peptides. For example, my research fellow,
En-Hsin Lee, has developed the flow-chip to study the function of changing pH on
anthrax toxin. I anticipate that these methods of DIBs will be applied to study other
membrane transport systems extensively. 1, 5
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